A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
Public ClinicalTrials.gov record NCT06914895. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Tirzepatide Once Weekly Compared to Placebo in Adult Participants With Type 1 Diabetes and Obesity or Overweight
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 weeks.
Study identification
- NCT ID
- NCT06914895
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 905 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 25, 2025 (Actual)
- Primary completion
- Nov 2026 (Estimated)
- Completion
- Dec 2026 (Estimated)
- Last update posted
- May 12, 2026
2025 – 2026
United States locations
- U.S. sites
- 31
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sansum Diabetes Research Institute | Santa Barbara | California | 93105 | — |
| Care Access - Santa Clarita | Santa Clarita | California | 91321 | — |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30318 | — |
| Orita Clinical Research | Decatur | Georgia | 30034 | — |
| North Georgia Clinical Research | Woodstock | Georgia | 30189 | — |
| East-West Medical Research Institute | Honolulu | Hawaii | 96814 | — |
| Rocky Mountain Clinical Research | Idaho Falls | Idaho | 83404 | — |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62702 | — |
| Indiana University Health University Hospital | Indianapolis | Indiana | 46202 | — |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50266 | — |
| Endocrine and Metabolic Consultants | Rockville | Maryland | 20852 | — |
| HealthPartners Institute dba International Diabetes Center | Minneapolis | Minnesota | 55416 | — |
| SKY Integrative Medical Center/SKYCRNG | Ridgeland | Mississippi | 39157 | — |
| Boeson Research MSO | Missoula | Montana | 59804 | — |
| Palm Research Center Tenaya | Las Vegas | Nevada | 89128 | — |
| Palm Research Center Sunset | Las Vegas | Nevada | 89148 | — |
| Albany Medical College, Division of Community Endocrinology | Albany | New York | 12203 | — |
| Research Foundation of SUNY - University of Buffalo | Buffalo | New York | 14221 | — |
| NYC Research | New York | New York | 10016 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| Lucas Research, Inc. | Morehead City | North Carolina | 28557 | — |
| Care Access - Lima | Lima | Ohio | 45805 | — |
| Alliance for Multispecialty Research, LLC | Norman | Oklahoma | 73069 | — |
| Suburban Research Associates | West Chester | Pennsylvania | 19380 | — |
| Texas Diabetes & Endocrinology, P.A. | Austin | Texas | 78731 | — |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | — |
| Tekton Research, LLC. | McKinney | Texas | 75069 | — |
| Medrasa Clinical Research | Wylie | Texas | 75098 | — |
| Eastside Research Associates | Redmond | Washington | 98052 | — |
| Rainier Clinical Research Center | Renton | Washington | 98057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06914895, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06914895 live on ClinicalTrials.gov.